(Q45176540)

English

Combination therapy with venlafaxine and carbamazepine in depressive patients not responding to venlafaxine: pharmacokinetic and clinical aspects

scientific article published in December 2004

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

10 December 2017

Combination therapy with venlafaxine and carbamazepine in depressive patients not responding to venlafaxine: pharmacokinetic and clinical aspects. (English)

1 reference

Europe PubMed Central

PubMed publication ID

10 December 2017

1 reference

based on heuristic

inferred from title

pharmacokinetics

1 reference

based on heuristic

inferred from title

object named as

Chin B Eap

3

0 references

author name string

Elio Ciusani

1

1 reference

Europe PubMed Central

PubMed publication ID

10 December 2017

Daniele F Zullino

2

1 reference

Europe PubMed Central

PubMed publication ID

10 December 2017

Marlyse Brawand-Amey

4

1 reference

Europe PubMed Central

PubMed publication ID

10 December 2017

Murielle Brocard

5

1 reference

Europe PubMed Central

PubMed publication ID

10 December 2017

Pierre Baumann

6

1 reference

Europe PubMed Central

PubMed publication ID

10 December 2017

language of work or name

0 references

publication date

1 December 2004

1 reference

Europe PubMed Central

PubMed publication ID

10 December 2017

Journal of Psychopharmacology

1 reference

Europe PubMed Central

PubMed publication ID

10 December 2017

18

1 reference

Europe PubMed Central

PubMed publication ID

10 December 2017

4

1 reference

Europe PubMed Central

PubMed publication ID

10 December 2017

559-566

1 reference

Europe PubMed Central

PubMed publication ID

10 December 2017

Carbamazepine clinical pharmacology: a review

1 reference

https://api.crossref.org/works/10.1177%2F026988110401800414

21 January 2018

Lithium augmentation in treatment-resistant depression: meta-analysis of placebo-controlled studies

1 reference

https://api.crossref.org/works/10.1177%2F026988110401800414

21 January 2018

Venlafaxine: discrepancy between in vivo 5-HT and NE reuptake blockade and affinity for reuptake sites

1 reference

https://api.crossref.org/works/10.1177%2F026988110401800414

21 January 2018

Role of the smoking-induced cytochrome P450 (CYP)1A2 and polymorphic CYP2D6 in steady-state concentration of olanzapine

1 reference

https://api.crossref.org/works/10.1177%2F026988110401800414

21 January 2018

Carbamazepine-induced release of serotonin from rat hippocampus in vitro

1 reference

https://api.crossref.org/works/10.1177%2F026988110401800414

21 January 2018

Carbamazepine addition in tricyclic antidepressant-resistant unipolar depression

1 reference

https://api.crossref.org/works/10.1177%2F026988110401800414

21 January 2018

Role of CYP2D6 in the stereoselective disposition of venlafaxine in humans

1 reference

https://api.crossref.org/works/10.1177%2F026988110401800414

21 January 2018

Therapeutic drug monitoring for the treatment of psychiatric disorders. Clinical use and cost effectiveness

1 reference

https://api.crossref.org/works/10.1177%2F026988110401800414

21 January 2018

O- and N-demethylation of venlafaxine in vitro by human liver microsomes and by microsomes from cDNA-transfected cells: effect of metabolic inhibitors and SSRI antidepressants

1 reference

https://api.crossref.org/works/10.1177%2F026988110401800414

21 January 2018

The serotonin syndrome scale: first results on validity.

1 reference

https://api.crossref.org/works/10.1177%2F026988110401800414

21 January 2018

Serotonin syndrome due to venlafaxine and maintenance tranylcypromine therapy

1 reference

https://api.crossref.org/works/10.1177%2F026988110401800414

21 January 2018

Lithium augmentation of venlafaxine: an open-label trial

1 reference

https://api.crossref.org/works/10.1177%2F026988110401800414

21 January 2018

Venlafaxine. A review of its pharmacology and therapeutic potential in depression

1 reference

https://api.crossref.org/works/10.1177%2F026988110401800414

21 January 2018

Toxic interaction of venlafaxine and isocarboxazide

1 reference

https://api.crossref.org/works/10.1177%2F026988110401800414

21 January 2018

Autoinduction and steady-state pharmacokinetics of carbamazepine and its major metabolites

1 reference

https://api.crossref.org/works/10.1177%2F026988110401800414

21 January 2018

Diphenhydramine alters the disposition of venlafaxine through inhibition of CYP2D6 activity in humans

1 reference

https://api.crossref.org/works/10.1177%2F026988110401800414

21 January 2018

Venlafaxine- and trazodone-induced serotonin syndrome

1 reference

https://api.crossref.org/works/10.1177%2F026988110401800414

21 January 2018

Spontaneous lapses in dosing during chronic treatment with selective serotonin reuptake inhibitors

1 reference

https://api.crossref.org/works/10.1177%2F026988110401800414

21 January 2018

A case of serotonin syndrome caused by venlafaxine and lithium

1 reference

https://api.crossref.org/works/10.1177%2F026988110401800414

21 January 2018

A New Depression Scale Designed to be Sensitive to Change

1 reference

https://api.crossref.org/works/10.1177%2F026988110401800414

21 January 2018

Venlafaxine oxidation in vitro is catalysed by CYP2D6.

1 reference

https://api.crossref.org/works/10.1177%2F026988110401800414

21 January 2018

Therapeutic drug monitoring of racemic venlafaxine and its main metabolites in an everyday clinical setting

1 reference

https://api.crossref.org/works/10.1177%2F026988110401800414

21 January 2018

Carbamazepine augmentation in depressive patients non-responding to citalopram: a pharmacokinetic and clinical pilot study

1 reference

https://api.crossref.org/works/10.1177%2F026988110401800414

21 January 2018

Venlafaxine serum levels and CYP2D6 genotype

1 reference

https://api.crossref.org/works/10.1177%2F026988110401800414

21 January 2018

Lithium augmentation in depressive patients not responding to selective serotonin reuptake inhibitors

1 reference

https://api.crossref.org/works/10.1177%2F026988110401800414

21 January 2018

Lithium augmentation in venlafaxine-refractory depression

1 reference

https://api.crossref.org/works/10.1177%2F026988110401800414

21 January 2018

Effects of Carbamazepine Coadministration on Plasma Concentrations of the Enantiomers of Mianserin and of its Metabolites

1 reference

https://api.crossref.org/works/10.1177%2F026988110401800414

21 January 2018

Marked Increase of Venlafaxine Enantiomer Concentrations as a Consequence of Metabolic Interactions: A Case Report

1 reference

https://api.crossref.org/works/10.1177%2F026988110401800414

21 January 2018

Genotyping of poor metabolisers of debrisoquine by allele-specific PCR amplification

1 reference

https://api.crossref.org/works/10.1177%2F026988110401800414

21 January 2018

Identifiers

10.1177/026988110401800414

1 reference

Europe PubMed Central

PubMed publication ID

10 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

10 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45176540&oldid=2143726974"